Multiple projects have been jointly developed between INS and CDC, including enhanced surveillance of pregnant women with symptomatic Zika virus disease. CDC seeks to implement a prospective cohort study in which we will follow women enrolled in the first trimester of pregnancy, their male partners, and their children in several cities in Colombia in which ZIKV transmission is currently ongoing. This is a continuation study to collect data on the OMB-approved Emergency Clearance package 0920-1142, and the Standard ICR 0920-1190, which covered collection of infants out to six months old. This Revision ICR will collect information on infants from 6 months out to two years after birth.
Submission of this Revision for 0920-1190 ZEN Colombia Study: Zika in Pregnant Women and Children in Colombia reflects 1) decrease in burden hours because of lowering number of remaining respondents to 500 pregnant women and 125 male partners during the pregnancy follow-up, as enrollment is progressing, and 2) increase in burden hours with the addition of data collection to follow 900 children from 6 months to 2 years of age
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.